Cargando…

108. Impact of Accelerate Pheno System in the Management of Gram-Negative Rod Bacteremia

BACKGROUND: Early pathogen identification and initiation of appropriate antimicrobial therapy is key in the management of Gram-negative rods (GNR) bloodstream infection (BSI). The Accelerate Pheno System (ACC) has been shown to reduce time to GNR identification compared to traditional culture-based...

Descripción completa

Detalles Bibliográficos
Autores principales: Ganapathiraju, Iaswarya, Bushman, Amanda, Espinoza, Rossana Rosa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777970/
http://dx.doi.org/10.1093/ofid/ofaa439.153
_version_ 1783631028085063680
author Ganapathiraju, Iaswarya
Bushman, Amanda
Espinoza, Rossana Rosa
author_facet Ganapathiraju, Iaswarya
Bushman, Amanda
Espinoza, Rossana Rosa
author_sort Ganapathiraju, Iaswarya
collection PubMed
description BACKGROUND: Early pathogen identification and initiation of appropriate antimicrobial therapy is key in the management of Gram-negative rods (GNR) bloodstream infection (BSI). The Accelerate Pheno System (ACC) has been shown to reduce time to GNR identification compared to traditional culture-based methods. We aimed to determine the impact of ACC on the management of GNR BSI in the setting of a well-established antimicrobial stewardship program (ASP). Table 1 [Image: see text] METHODS: ACC was introduced in our institution on February 2019. Due to issues incorporating ACC, of patients with GNR BSI, 74% had ACC done and 26% had reporting through traditional methods. This allowed for the design of a retrospective cohort study (instead of a pre-post analysis) to evaluate the association of interest. We included adult patients admitted to three affiliated hospitals in Des Moines, Iowa with BSI due to Enterobacteriales from February 2019 to February 2020. Exclusion criteria were Emergency Department visit only and death within 48 hours of blood culture collection. Primary outcomes were length of hospital stay, days to therapy optimization and in-hospital mortality. Continuous variables were compared by non-parametric methods and categorical variables were compared by Chi-square and Fisher-exact test. Logistic regression models were used to calculate odds ratio for the impact of the intervention on therapy optimization. RESULTS: A total of 268 patients were analyzed. The median length of stay among patients who had ACC done was 5.2 days (IQR 3.6–8.7) and in those on who ACC was not done it was 5.5 (IQR 3.8–8.9) (p=0.54). No differences in in-hospital mortality were found (p=0.942). Changes in therapy and missed opportunities for optimization according to whether ACC was done are shown in Table 1. Patients who had ACC done had 99% higher odds of de-escalation within 48 hours of blood culture collection compared to patients who did not have it done (95% CI 1.01–3.92; p=0.044). CONCLUSION: In the context of hospitals with baseline short length of stay and a well-established ASP, performing ACC was associated with higher odds of de-escalation within 48 hours of blood culture collection but did not impact length of stay or mortality among patients hospitalized with GNR BSI. DISCLOSURES: All Authors: No reported disclosures
format Online
Article
Text
id pubmed-7777970
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-77779702021-01-07 108. Impact of Accelerate Pheno System in the Management of Gram-Negative Rod Bacteremia Ganapathiraju, Iaswarya Bushman, Amanda Espinoza, Rossana Rosa Open Forum Infect Dis Poster Abstracts BACKGROUND: Early pathogen identification and initiation of appropriate antimicrobial therapy is key in the management of Gram-negative rods (GNR) bloodstream infection (BSI). The Accelerate Pheno System (ACC) has been shown to reduce time to GNR identification compared to traditional culture-based methods. We aimed to determine the impact of ACC on the management of GNR BSI in the setting of a well-established antimicrobial stewardship program (ASP). Table 1 [Image: see text] METHODS: ACC was introduced in our institution on February 2019. Due to issues incorporating ACC, of patients with GNR BSI, 74% had ACC done and 26% had reporting through traditional methods. This allowed for the design of a retrospective cohort study (instead of a pre-post analysis) to evaluate the association of interest. We included adult patients admitted to three affiliated hospitals in Des Moines, Iowa with BSI due to Enterobacteriales from February 2019 to February 2020. Exclusion criteria were Emergency Department visit only and death within 48 hours of blood culture collection. Primary outcomes were length of hospital stay, days to therapy optimization and in-hospital mortality. Continuous variables were compared by non-parametric methods and categorical variables were compared by Chi-square and Fisher-exact test. Logistic regression models were used to calculate odds ratio for the impact of the intervention on therapy optimization. RESULTS: A total of 268 patients were analyzed. The median length of stay among patients who had ACC done was 5.2 days (IQR 3.6–8.7) and in those on who ACC was not done it was 5.5 (IQR 3.8–8.9) (p=0.54). No differences in in-hospital mortality were found (p=0.942). Changes in therapy and missed opportunities for optimization according to whether ACC was done are shown in Table 1. Patients who had ACC done had 99% higher odds of de-escalation within 48 hours of blood culture collection compared to patients who did not have it done (95% CI 1.01–3.92; p=0.044). CONCLUSION: In the context of hospitals with baseline short length of stay and a well-established ASP, performing ACC was associated with higher odds of de-escalation within 48 hours of blood culture collection but did not impact length of stay or mortality among patients hospitalized with GNR BSI. DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2020-12-31 /pmc/articles/PMC7777970/ http://dx.doi.org/10.1093/ofid/ofaa439.153 Text en © The Author 2020. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Poster Abstracts
Ganapathiraju, Iaswarya
Bushman, Amanda
Espinoza, Rossana Rosa
108. Impact of Accelerate Pheno System in the Management of Gram-Negative Rod Bacteremia
title 108. Impact of Accelerate Pheno System in the Management of Gram-Negative Rod Bacteremia
title_full 108. Impact of Accelerate Pheno System in the Management of Gram-Negative Rod Bacteremia
title_fullStr 108. Impact of Accelerate Pheno System in the Management of Gram-Negative Rod Bacteremia
title_full_unstemmed 108. Impact of Accelerate Pheno System in the Management of Gram-Negative Rod Bacteremia
title_short 108. Impact of Accelerate Pheno System in the Management of Gram-Negative Rod Bacteremia
title_sort 108. impact of accelerate pheno system in the management of gram-negative rod bacteremia
topic Poster Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777970/
http://dx.doi.org/10.1093/ofid/ofaa439.153
work_keys_str_mv AT ganapathirajuiaswarya 108impactofacceleratephenosysteminthemanagementofgramnegativerodbacteremia
AT bushmanamanda 108impactofacceleratephenosysteminthemanagementofgramnegativerodbacteremia
AT espinozarossanarosa 108impactofacceleratephenosysteminthemanagementofgramnegativerodbacteremia